home / stock / npce / npce news

NPCE News and Press, Neuropace Inc. From 06/24/25

Stock Information
Company Name: Neuropace Inc.
Stock Symbol: NPCE
Market: NASDAQ
Website: neuropace.com
Menu
NPCE NPCE Quote NPCE Short NPCE News NPCE Articles NPCE Message Board
Get NPCE Alerts

News, Short Squeeze, Breakout and More Instantly...
NPCE - NeuroPace appoints Patrick Williams as CFO

2025-06-24 16:09:33 ET More on NeuroPace NeuroPace, Inc. (NPCE) Q1 2025 Earnings Call Transcript NeuroPace, Inc. 2025 Q1 - Results - Earnings Call Presentation NeuroPace secures $75M credit facility with MidCap Financial NeuroPace falls after setback in trial...
NPCE - NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of NeuroPace, Inc. (“NeuroPace” or “the Company”) (NASDAQ: NPCE ) for violations of the securities laws. The investigation fo...

NPCE - NeuroPace secures $75M credit facility with MidCap Financial

2025-06-04 16:30:29 ET More on NeuroPace NeuroPace, Inc. (NPCE) Q1 2025 Earnings Call Transcript NeuroPace, Inc. 2025 Q1 - Results - Earnings Call Presentation NeuroPace falls after setback in trial for neuromodulation system NeuroPace reports Q1 results; rai...

NPCE - NeuroPace Secures Up to $75 Million in Debt Financing

MOUNTAIN VIEW, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company has entered into a new $75 million credit facility with MidCap Financial, consisting...
NPCE - NeuroPace falls after setback in trial for neuromodulation system

2025-05-27 09:04:32 ET More on NeuroPace NeuroPace, Inc. (NPCE) Q1 2025 Earnings Call Transcript NeuroPace, Inc. 2025 Q1 - Results - Earnings Call Presentation NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript NeuroPace reports Q1 results; raises FY25 o...

NPCE - NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study

-- NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluate neuromodulation therapy for idiopathic generalized epilepsy -- Study met the 12-week post-implant primary safety endpoint, demonstrating excellent safety outcom...

NPCE - Expected US Company Earnings on Wednesday, May 14th, 2025

Aeva Technologies Inc. (AEVA) is expected to report $-0.59 for Q1 2025 Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil) (LND) is expected to report for Q3 2025 Omron Corporation ADR (OMRNY) is expected to report for Q4 2025 Sezzle Inc. (SEZL) is expected to report $0.3...
NPCE - NeuroPace reports Q1 results; raises FY25 outlook

2025-05-14 03:57:29 ET More on NeuroPace NeuroPace, Inc. (NPCE) Q1 2025 Earnings Call Transcript NeuroPace, Inc. 2025 Q1 - Results - Earnings Call Presentation NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript NeuroPace outlines 20%+ CAGR through 2027 a...

NPCE - NeuroPace outlines 20%+ CAGR through 2027 as RNS business momentum accelerates

2025-05-13 22:34:17 ET More on NeuroPace NeuroPace, Inc. (NPCE) Q1 2025 Earnings Call Transcript NeuroPace, Inc. 2025 Q1 - Results - Earnings Call Presentation NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript NeuroPace expects minimal impact of tariffs...

NPCE - NeuroPace, Inc. (NPCE) Q1 2025 Earnings Call Transcript

2025-05-13 22:33:37 ET NeuroPace, Inc. (NPCE) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Jeremy Feffer - LifeSci Advisors Joel Becker - Chief Executive Officer Rebecca Kuhn - Chief Financial Officer Conference Call Partici...
Previous 10 Next 10